SAN FRANCISCO, Dec. 5, 2016 /PRNewswire/ -- Recently Zymo Research announced an exclusive license agreement for a methylation age predictor, known as Horvath's Clock. Based on this technology, Zymo Research is now offering a sample analysis service to academic and biopharma scientific researchers to determine the biological age of any human sample, other than sperm. The service quantifies changes in methylation patterns to accurately estimate biological age versus chronological age following drug treatments and identifies disease associated aging alterations.
The sample analysis detects methylation changes at over 350 CpG sites associated with aging. A detailed report will be provided showing an accurate epigenetic age estimate. The service can be customized; however, all customers will receive the sample's chronological age, DNA age, age difference, and visualizations of those statistics.
Dr. Graham Threadgill, Vice President of Global Marketing at Zymo Research, commented, "The Horvath Clock technology is an important part of Zymo Research's aging program and we are pleased to announce our first commercialized sample analysis service based on this technology. This service can facilitate research on such diseases as Huntington's Disease, Down Syndrome or HIV-1-infection research, for example."